Find information on thousands of medical conditions and prescription drugs.

Oruvail

Ketoprofen, (RS)2-(3-benzoylphenyl)-propionic acid (chemical formula C₁₆H₁₄O₃) is one of the propionic acid class of non-steroidal anti-inflammatory drug (NSAID) with analgesic and anti-pyretic effects. It acts by inhibiting the body's production of prostaglandin.

Ketoprofen is available OTC in the United States in the form of 12.5mg coated tablets (Orudis KT®). It is also available by prescription as 25, 50, 75, 100, 150, and 200mg capsules.

Brand names in the US are Orudis and Oruvail.

Home

OCL

Oncovin

Opium

Oratane

Oretic

Orinase

Oruvail

Ovcon

Ovral

Ovrette

Oxetine

Read more at Wikipedia.org

• [List your site here Free!]



	Soothing athletic aches: can't decide between aspirin and ibuprofen? Here's the latest on over-the-counter pain meds there's a reason why the athletes who are in Athens this summer are there: They're talented, they're tough, and when it comes to handling pain, they're ... From Muscle & Fitness/Hers, 8/1/04 by Dana Sullivan

	FDA Approves ANDA for Oruvail FORT LAUDERDALE, Fla. and CORONA, Calif.--(BUSINESS WIRE)--March 30, 1999--Andrx Corporation (Nasdaq:ADRX) and Watson Pharmaceuticals, Inc. (NYSE:WPI) ... From Business Wire, 3/30/99

	FDA Oks Andrx's rheumatoid arthritis drug The Food and Drug Administration has approved Andrx Pharmaceuticals Inc.'s abbreviated new drug application for Ketoprofen extended-release capsules, ... From Drug Store News, 5/17/99

	Arthritis drug pulled by maker Before Eileen Burden began taking the popular arthritis drug Vioxx, her joints ached so much she could barely get dressed in the morning. A few months later, the 65-year-old Elk Grove Village w From Chicago Sun-Times, 10/1/04 by Lori Rackl

	Wyeth-Ayerst's ORUVAIL® receives market clearance for two new strengths PHILADELPHIA--(BUSINESS WIRE)--Feb. 15, 1995--Wyeth-Ayerst Laboratories, Division of American Home Products Corporation (NYSE:AHP), today announced ... From Business Wire, 2/15/95

	Similar-sounding drugs: What's in a name? A possible mix-up, that's what. You can avoid mixing up soundalike or look-alike drugs, such as the ones listed below, several ways. For example, double-check ... From Nursing, 10/1/96 by Cohen, Michael R

	Andrx Reports Earnings for Three and Six Months Ended June 30, 1999 FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--July 27, 1999-- ANDRX CORPORATION (Nasdaq:ADRX) today announced its results for the three and six month periods ... From Business Wire, 7/27/99

	Andrx Reports Continued Increase in Profits FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--April 27, 1999-- ANDRX CORPORATION (Nasdaq:ADRX) today announced its results for the three months ended March ... From Business Wire, 4/27/99

Home

Contact

Resources

Exchange Links

ebay